RHON-KLINIKUM AG Unsponsored ADR (ADR)

Factors to consider:

• Company pays dividends (annually): last record date 2025-06-05, amount 0.05$ (Y0.68%)
• Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

• 2024-12-31 to 2025-12-31 estimated range: [4.90$, 7.53$]
• 2025-12-31 to 2026-12-31 estimated range: [5.32$, 8.05$]

Financial Metrics affecting the RKAGY estimates:

• Positive: with PPE of 8.5 at the end of fiscal year the price was very low
• Positive: -3.60 < Operating profit margin, % of 3.02
• Positive: Operating cash flow per share per price, % of 17.06 > 13.24
• Positive: Interest expense per share per price, % of 0.45 <= 0.79
• Positive: Inventory ratio change, % of 0.01 <= 0.84
• Negative: Investing cash flow per share per price, % of -6.74 <= -4.48
• Negative: Industry operating cash flow per share per price (median), % of 3.25 <= 5.52
• Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 2.38
• Positive: Shareholder equity ratio, % of 69.81 > 63.39
• Negative: -0.15 < Industry inventory ratio change (median), % of 0